Asahi Kasei Expands into IAQ Sensors and Orphan‑Drug Therapy, Boosting Diversified Growth
Asahi Kasei launches a CO₂ indoor‑air‑quality sensor and its Veloxis sub‑company gets FDA orphan‑drug status for a transplant drug—showing a smart, multi‑sector innovation strategy that diversifies revenue while tapping growth in IAQ and niche thera…
3 minutes to read









